Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

61 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
International and Interdisciplinary Identification of Health Care Transition Outcomes.
Fair C, Cuttance J, Sharma N, Maslow G, Wiener L, Betz C, Porter J, McLaughlin S, Gilleland-Marchak J, Renwick A, Naranjo D, Jan S, Javalkar K, Ferris M; International and Interdisciplinary Health Care Transition Research Consortium. Fair C, et al. JAMA Pediatr. 2016 Mar;170(3):205-11. doi: 10.1001/jamapediatrics.2015.3168. JAMA Pediatr. 2016. PMID: 26619178 Free PMC article.
Results of a healthcare transition learning collaborative for emerging adults with sickle cell disease: the ST3P-UP study transition quality improvement collaborative.
Osunkwo I, Cornette JS, Noonan L, Courtlandt C, Mabus S, White PH, McManus M, Robinson MM, Wallander ML, Eckman JR, Saah E, Alvarez OA, Goodwin M, Jerome Clay L, Desai P, Lawrence RH. Osunkwo I, et al. BMJ Qual Saf. 2024 Nov 21:bmjqs-2024-017725. doi: 10.1136/bmjqs-2024-017725. Online ahead of print. BMJ Qual Saf. 2024. PMID: 39577868
Multicenter, phase 1 study of etavopivat (FT-4202) treatment for up to 12 weeks in patients with sickle cell disease.
Saraf SL, Hagar R, Idowu M, Osunkwo I, Cruz K, Kuypers FA, Brown RC, Geib J, Ribadeneira M, Schroeder P, Wu E, Forsyth S, Kelly PF, Kalfa TA, Telen MJ. Saraf SL, et al. Among authors: osunkwo i. Blood Adv. 2024 Aug 27;8(16):4459-4475. doi: 10.1182/bloodadvances.2023012467. Blood Adv. 2024. PMID: 38640200 Free PMC article. Clinical Trial.
A comparison of the effect of patient-specific versus weight-based protocols to treat vaso-occlusive episodes in the emergency department.
Tanabe P, Ibemere S, Pierce AE, Freiermuth CE, Bosworth HB, Yang H, Osunkwo I, Paxton JH, Strouse JJ, Miller J, Paice JA, Veeramreddy P, Kavanagh PL, Wilkerson RG, Hughes R, Barnhart HX. Tanabe P, et al. Among authors: osunkwo i. Acad Emerg Med. 2023 Dec;30(12):1210-1222. doi: 10.1111/acem.14805. Epub 2023 Nov 12. Acad Emerg Med. 2023. PMID: 37731093 Free PMC article.
A clinician's view of voxelotor.
Osunkwo I, Anderson A, Brown RC, Shah N, Estepp JH. Osunkwo I, et al. Br J Haematol. 2022 Nov;199(4):616-618. doi: 10.1111/bjh.18455. Epub 2022 Sep 16. Br J Haematol. 2022. PMID: 36113859 No abstract available.
Burden of disease, treatment utilization, and the impact on education and employment in patients with sickle cell disease: A comparative analysis of high- and low- to middle-income countries for the international Sickle Cell World Assessment Survey.
Osunkwo I, James J, El-Rassi F, Nero A, Minniti CP, Trimnell C, Paulose J, Ramscar N, Bailey T, Rajkovic-Hooley O, Andemariam B. Osunkwo I, et al. Am J Hematol. 2022 Aug;97(8):1055-1064. doi: 10.1002/ajh.26576. Epub 2022 Jun 20. Am J Hematol. 2022. PMID: 35472249 Free PMC article.
61 results